VINCERX PHARMA INC (VINC) Stock Analyst Earnings Estimates
NASDAQ:VINC - Nasdaq - US92731L1061 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A 3,331.82% | N/A 227.15% | N/A 168.58% | N/A 71.96% | N/A 45.87% | ||||||
| EBITDA YoY % growth | N/A | N/A | -62.63M | -71.05M -13.44% | -42.557M 40.10% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -170K | -62.66M -36,758.82% | -71.1M -13.47% | -42.609M 40.07% | N/A 29.05% | N/A 6.80% | N/A -41.18% | N/A -64.10% | N/A 6.25% | N/A 45.00% | N/A 106.06% | N/A 2,000.00% | ||
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | -2.28 -2,383.66% | -3.12 -36.84% | -1.89 39.42% | N/A 58.98% | N/A 39.47% | N/A -23.91% | N/A -49.12% | N/A 12.94% | N/A 50.00% | N/A 113.51% | N/A 900.00% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.14 39.39% | -0.12 78.90% | -0.12 -144.80% | -0.12 28.00% | -0.11 19.51% |
| Revenue Q2Q % growth | |||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -6.781M -22.55% | -6.12M 18.16% | -6.12M 16.92% | -6.12M 21.47% | -6.12M 9.74% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.17 63.04% | -0.22 | 0.05 | 23.08% |
| Q2 2024 Q2Q % growth | -0.05 90.38% | -0.21 | 0.16 | 76.09% |
| Q1 2024 Q2Q % growth | -0.58 14.71% | -0.24 | -0.34 | -141.97% |
| Q4 2023 Q2Q % growth | -0.23 64.62% | -0.37 | 0.14 | 38.50% |
| Q3 2023 Q2Q % growth | -0.46 42.50% | -0.47 | 0.01 | 1.25% |
| Q2 2023 Q2Q % growth | -0.52 40.91% | -0.61 | 0.09 | 14.56% |
| Q1 2023 Q2Q % growth | -0.68 13.92% | -0.53 | -0.15 | -28.21% |
| Q4 2022 Q2Q % growth | -0.65 -109.68% | -0.63 | -0.02 | -3.62% |
| Q3 2022 Q2Q % growth | -0.80 42.45% | -0.56 | -0.24 | -41.96% |
| Q2 2022 Q2Q % growth | -0.88 -633.33% | -0.81 | -0.07 | -8.52% |
| Q1 2022 Q2Q % growth | -0.79 -71.74% | -0.77 | -0.02 | -2.45% |
| Q4 2021 Q2Q % growth | -0.31 | -0.95 | 0.64 | 67.39% |
| Q3 2021 Q2Q % growth | -1.39 | -0.86 | -0.53 | -60.70% |
| Q2 2021 Q2Q % growth | -0.12 | -0.38 | 0.26 | 68.63% |
| Q1 2021 Q2Q % growth | -0.46 | -0.33 | -0.13 | -40.93% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 28.07% | 0% | 3.8% |
| Revenue | N/A | N/A | N/A | N/A |